MYRIAM CUADRADO LÓPEZ-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

    Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553

  2. Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis

    EMBO Journal, Vol. 40, Núm. 22

  2. Distinct roles of vav family members in adaptive and innate immune models of arthritis

    Biomedicines, Vol. 9, Núm. 6

2020

  1. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma

    Nature Communications, Vol. 11, Núm. 1

  2. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor

    Oncogene, Vol. 39, Núm. 28, pp. 5098-5111